The Brain Exposure Efficiency (BEE) ScoreClick to copy article linkArticle link copied!
- Mayuri GuptaMayuri GuptaKrembil Research Institute, University Health Network, 60 Leonard Avenue, Toronto, Ontario M5T 2S8, CanadaMore by Mayuri Gupta
- Thomas BogdanowiczThomas BogdanowiczKrembil Research Institute, University Health Network, 60 Leonard Avenue, Toronto, Ontario M5T 2S8, CanadaMore by Thomas Bogdanowicz
- Mark A. ReedMark A. ReedKrembil Research Institute, University Health Network, 60 Leonard Avenue, Toronto, Ontario M5T 2S8, CanadaMore by Mark A. Reed
- Christopher J. BardenChristopher J. BardenKrembil Research Institute, University Health Network, 60 Leonard Avenue, Toronto, Ontario M5T 2S8, CanadaMore by Christopher J. Barden
- Donald F. Weaver*Donald F. Weaver*Email: [email protected]Krembil Research Institute, University Health Network, 60 Leonard Avenue, Toronto, Ontario M5T 2S8, CanadaDepartment of Medicine, University of Toronto, Toronto, Ontario M5G 2C4, CanadaDepartment of Chemistry, University of Toronto, Toronto, Ontario M5S 3H6, CanadaDepartment of Pharmaceutical Sciences, University of Toronto, Toronto, Ontario M5S 3M2 CanadaMore by Donald F. Weaver
Abstract

The blood-brain barrier (BBB), composed of microvascular tight junctions and glial cell sheathing, selectively controls drug permeation into the central nervous system (CNS) by either passive diffusion or active transport. Computational techniques capable of predicting molecular brain penetration are important to neurological drug design. A novel prediction algorithm, termed the Brain Exposure Efficiency Score (BEE), is presented. BEE addresses the need to incorporate the role of trans-BBB influx and efflux active transporters by considering key brain penetrance parameters, namely, steady state unbound brain to plasma ratio of drug (Kp,uu) and dose normalized unbound concentration of drug in brain (Cu,b). BEE was devised using quantitative structure–activity relationships (QSARs) and molecular modeling studies on known transporter proteins and their ligands. The developed algorithms are provided as a user-friendly open source calculator to assist in optimizing a brain penetrance strategy during the early phases of small molecule molecular therapeutic design.
Cited By
Smart citations by scite.ai include citation statements extracted from the full text of the citing article. The number of the statements may be higher than the number of citations provided by ACS Publications if one paper cites another multiple times or lower if scite has not yet processed some of the citing articles.
This article is cited by 14 publications.
- Isaac M. Jackson, E. William Webb, Peter J.H. Scott, Michelle L. James. In Silico Approaches for Addressing Challenges in CNS Radiopharmaceutical Design. ACS Chemical Neuroscience 2022, 13
(12)
, 1675-1683. https://doi.org/10.1021/acschemneuro.2c00269
- Baichen Xiong, Yuanyuan Wang, Ying Chen, Shuaishuai Xing, Qinghong Liao, Yao Chen, Qi Li, Wei Li, Haopeng Sun. Strategies for Structural Modification of Small Molecules to Improve Blood–Brain Barrier Penetration: A Recent Perspective. Journal of Medicinal Chemistry 2021, 64
(18)
, 13152-13173. https://doi.org/10.1021/acs.jmedchem.1c00910
- Giang H. Ta, Max K. Leong. A novel in silico approach for predicting unbound brain-to-plasma ratio using machine learning-based support vector regression. Computers in Biology and Medicine 2025, 192 , 110366. https://doi.org/10.1016/j.compbiomed.2025.110366
- Berfin Gülave, Helle W. van den Maagdenberg, Luke van Boven, Gerard J. P. van Westen, Elizabeth C. M. de Lange, J. G. Coen van Hasselt. Prediction of the Extent of Blood–Brain Barrier Transport Using Machine Learning and Integration into the LeiCNS-PK3.0 Model. Pharmaceutical Research 2025, 42
(2)
, 281-289. https://doi.org/10.1007/s11095-025-03828-0
- Maria Dichiara, Giuseppe Cosentino, Giorgia Giordano, Lorella Pasquinucci, Agostino Marrazzo, Giuliana Costanzo, Emanuele Amata. Designing drugs optimized for both blood–brain barrier permeation and intra-cerebral partition. Expert Opinion on Drug Discovery 2024, 19
(3)
, 317-329. https://doi.org/10.1080/17460441.2023.2294118
- Mayuri Gupta, Jun Feng, Govinda Bhisetti. Experimental and Computational Methods to Assess Central Nervous System Penetration of Small Molecules. Molecules 2024, 29
(6)
, 1264. https://doi.org/10.3390/molecules29061264
- Mohammed A. A. Saleh, Berfin Gülave, Olivia Campagne, Clinton F. Stewart, Jeroen Elassaiss-Schaap, Elizabeth C. M. de Lange. Using the LeiCNS-PK3.0 Physiologically-Based Pharmacokinetic Model to Predict Brain Extracellular Fluid Pharmacokinetics in Mice. Pharmaceutical Research 2023, 40
(11)
, 2555-2566. https://doi.org/10.1007/s11095-023-03554-5
- Mohammed A.A. Saleh, Makoto Hirasawa, Ming Sun, Berfin Gülave, Jeroen Elassaiss-Schaap, Elizabeth C.M. de Lange. The PBPK LeiCNS-PK3.0 framework predicts Nirmatrelvir (but not Remdesivir or Molnupiravir) to achieve effective concentrations against SARS-CoV-2 in human brain cells. European Journal of Pharmaceutical Sciences 2023, 181 , 106345. https://doi.org/10.1016/j.ejps.2022.106345
- Brendan J. Kelly, Elena Diez-Cecilia, Luzhe Pan, Braden Sweeting, Laura Villar, Alexander Kreft, Mayuri Gupta, Shea L. Johnson, Donald F. Weaver. A privileged dual action Alzheimer's disease therapeutic platform targeting immunopathic and proteopathic mechanisms: (
E
)-3-styrylindoles as inhibitors of indoleamine 2,3-dioxygenase-mediated tryptophan metabolism and β-amyloid aggregation. Canadian Journal of Chemistry 2022, 100
(9)
, 660-675. https://doi.org/10.1139/cjc-2021-0324
- Elizabeth C. M. de Lange, Margareta Hammarlund Udenaes. Understanding the Blood‐Brain Barrier and Beyond: Challenges and Opportunities for Novel CNS Therapeutics. Clinical Pharmacology & Therapeutics 2022, 111
(4)
, 758-773. https://doi.org/10.1002/cpt.2545
- Mayuri Gupta, Donald F. Weaver. Axonal plasma membrane-mediated toxicity of cholesterol in Alzheimer's disease: A microsecond molecular dynamics study. Biophysical Chemistry 2022, 281 , 106718. https://doi.org/10.1016/j.bpc.2021.106718
- Mayuri Gupta, Donald F. Weaver. Microsecond molecular dynamics studies of cholesterol-mediated myelin sheath degeneration in early Alzheimer's disease. Physical Chemistry Chemical Physics 2021, 24
(1)
, 222-239. https://doi.org/10.1039/D1CP03844C
- Yong Zheng, Paul M. Stafford, Kurt R. Stover, Darapaneni Chandra Mohan, Mayuri Gupta, Eric C. Keske, Paolo Schiavini, Laura Villar, Fan Wu, Alexander Kreft, Kiersten Thomas, Elana Raaphorst, Jagadeesh P. Pasangulapati, Siva R. Alla, Simmi Sharma, Ramana R. Mittapalli, Irina Sagamanova, Shea L. Johnson, Mark A. Reed, Donald F. Weaver. A Series of 2‐((1‐Phenyl‐1H‐imidazol‐5‐yl)methyl)‐1H‐indoles as Indoleamine 2,3‐Dioxygenase 1 (IDO1) Inhibitors. ChemMedChem 2021, 16
(14)
, 2195-2205. https://doi.org/10.1002/cmdc.202100107
- Zhiyu Wang, Yanfei Wang, Prachi Vilekar, Seung-Pil Yang, Mayuri Gupta, Myong In Oh, Autumn Meek, Lisa Doyle, Laura Villar, Anja Brennecke, Imindu Liyanage, Mark Reed, Christopher Barden, Donald F. Weaver. Small molecule therapeutics for COVID-19: repurposing of inhaled furosemide. PeerJ 2020, 8 , e9533. https://doi.org/10.7717/peerj.9533
Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.
Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.
The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.